These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

807 related articles for article (PubMed ID: 29110848)

  • 1. Relationship between nodule count and lung cancer probability in baseline CT lung cancer screening: The NELSON study.
    Heuvelmans MA; Walter JE; Peters RB; Bock GH; Yousaf-Khan U; Aalst CMV; Groen HJM; Nackaerts K; Ooijen PMV; Koning HJ; Oudkerk M; Vliegenthart R
    Lung Cancer; 2017 Nov; 113():45-50. PubMed ID: 29110848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between the number of new nodules and lung cancer probability in incidence screening rounds of CT lung cancer screening: The NELSON study.
    Walter JE; Heuvelmans MA; de Bock GH; Yousaf-Khan U; Groen HJM; van der Aalst CM; Nackaerts K; van Ooijen PMA; de Koning HJ; Vliegenthart R; Oudkerk M
    Lung Cancer; 2018 Nov; 125():103-108. PubMed ID: 30429006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Occurrence and lung cancer probability of new solid nodules at incidence screening with low-dose CT: analysis of data from the randomised, controlled NELSON trial.
    Walter JE; Heuvelmans MA; de Jong PA; Vliegenthart R; van Ooijen PMA; Peters RB; Ten Haaf K; Yousaf-Khan U; van der Aalst CM; de Bock GH; Mali W; Groen HJM; de Koning HJ; Oudkerk M
    Lancet Oncol; 2016 Jul; 17(7):907-916. PubMed ID: 27283862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lung cancer probability in patients with CT-detected pulmonary nodules: a prespecified analysis of data from the NELSON trial of low-dose CT screening.
    Horeweg N; van Rosmalen J; Heuvelmans MA; van der Aalst CM; Vliegenthart R; Scholten ET; ten Haaf K; Nackaerts K; Lammers JW; Weenink C; Groen HJ; van Ooijen P; de Jong PA; de Bock GH; Mali W; de Koning HJ; Oudkerk M
    Lancet Oncol; 2014 Nov; 15(12):1332-41. PubMed ID: 25282285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of three software systems for semi-automatic volumetry of pulmonary nodules on baseline and follow-up CT examinations.
    Zhao YR; van Ooijen PM; Dorrius MD; Heuvelmans M; de Bock GH; Vliegenthart R; Oudkerk M
    Acta Radiol; 2014 Jul; 55(6):691-8. PubMed ID: 24132766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Probability of cancer in pulmonary nodules detected on first screening CT.
    McWilliams A; Tammemagi MC; Mayo JR; Roberts H; Liu G; Soghrati K; Yasufuku K; Martel S; Laberge F; Gingras M; Atkar-Khattra S; Berg CD; Evans K; Finley R; Yee J; English J; Nasute P; Goffin J; Puksa S; Stewart L; Tsai S; Johnston MR; Manos D; Nicholas G; Goss GD; Seely JM; Amjadi K; Tremblay A; Burrowes P; MacEachern P; Bhatia R; Tsao MS; Lam S
    N Engl J Med; 2013 Sep; 369(10):910-9. PubMed ID: 24004118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting Malignancy Risk of Screen-Detected Lung Nodules-Mean Diameter or Volume.
    Tammemagi M; Ritchie AJ; Atkar-Khattra S; Dougherty B; Sanghera C; Mayo JR; Yuan R; Manos D; McWilliams AM; Schmidt H; Gingras M; Pasian S; Stewart L; Tsai S; Seely JM; Burrowes P; Bhatia R; Haider EA; Boylan C; Jacobs C; van Ginneken B; Tsao MS; Lam S;
    J Thorac Oncol; 2019 Feb; 14(2):203-211. PubMed ID: 30368011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Malignancy risk estimation of screen-detected nodules at baseline CT: comparison of the PanCan model, Lung-RADS and NCCN guidelines.
    van Riel SJ; Ciompi F; Jacobs C; Winkler Wille MM; Scholten ET; Naqibullah M; Lam S; Prokop M; Schaefer-Prokop C; van Ginneken B
    Eur Radiol; 2017 Oct; 27(10):4019-4029. PubMed ID: 28293773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Projected outcomes using different nodule sizes to define a positive CT lung cancer screening examination.
    Gierada DS; Pinsky P; Nath H; Chiles C; Duan F; Aberle DR
    J Natl Cancer Inst; 2014 Nov; 106(11):. PubMed ID: 25326638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics of new solid nodules detected in incidence screening rounds of low-dose CT lung cancer screening: the NELSON study.
    Walter JE; Heuvelmans MA; Bock GH; Yousaf-Khan U; Groen HJM; Aalst CMV; Nackaerts K; Ooijen PMAV; Koning HJ; Vliegenthart R; Oudkerk M
    Thorax; 2018 Aug; 73(8):741-747. PubMed ID: 29661918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of Prediction Models for Identifying Malignancy in Pulmonary Nodules Detected via Low-Dose Computed Tomography.
    González Maldonado S; Delorme S; Hüsing A; Motsch E; Kauczor HU; Heussel CP; Kaaks R
    JAMA Netw Open; 2020 Feb; 3(2):e1921221. PubMed ID: 32058555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating the Patient With a Pulmonary Nodule: A Review.
    Mazzone PJ; Lam L
    JAMA; 2022 Jan; 327(3):264-273. PubMed ID: 35040882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Features of resolving and nonresolving indeterminate pulmonary nodules at follow-up CT: the NELSON study.
    Zhao YR; Heuvelmans MA; Dorrius MD; van Ooijen PM; Wang Y; de Bock GH; Oudkerk M; Vliegenthart R
    Radiology; 2014 Mar; 270(3):872-9. PubMed ID: 24475806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New Fissure-Attached Nodules in Lung Cancer Screening: A Brief Report From The NELSON Study.
    Han D; Heuvelmans MA; van der Aalst CM; van Smoorenburg LH; Dorrius MD; Rook M; Nackaerts K; Walter JE; Groen HJM; Vliegenthart R; de Koning HJ; Oudkerk M
    J Thorac Oncol; 2020 Jan; 15(1):125-129. PubMed ID: 31606605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disagreement of diameter and volume measurements for pulmonary nodule size estimation in CT lung cancer screening.
    Heuvelmans MA; Walter JE; Vliegenthart R; van Ooijen PMA; De Bock GH; de Koning HJ; Oudkerk M
    Thorax; 2018 Aug; 73(8):779-781. PubMed ID: 29056601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Limited value of shape, margin and CT density in the discrimination between benign and malignant screen detected solid pulmonary nodules of the NELSON trial.
    Xu DM; van Klaveren RJ; de Bock GH; Leusveld A; Zhao Y; Wang Y; Vliegenthart R; de Koning HJ; Scholten ET; Verschakelen J; Prokop M; Oudkerk M
    Eur J Radiol; 2008 Nov; 68(2):347-52. PubMed ID: 17920800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deep Learning for Malignancy Risk Estimation of Pulmonary Nodules Detected at Low-Dose Screening CT.
    Venkadesh KV; Setio AAA; Schreuder A; Scholten ET; Chung K; W Wille MM; Saghir Z; van Ginneken B; Prokop M; Jacobs C
    Radiology; 2021 Aug; 300(2):438-447. PubMed ID: 34003056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. External validation and recalibration of the Brock model to predict probability of cancer in pulmonary nodules using NLST data.
    Winter A; Aberle DR; Hsu W
    Thorax; 2019 Jun; 74(6):551-563. PubMed ID: 30898897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of baseline nodule density and changes in density and nodule features in the discrimination between benign and malignant solid indeterminate pulmonary nodules.
    Xu DM; van Klaveren RJ; de Bock GH; Leusveld AL; Dorrius MD; Zhao Y; Wang Y; de Koning HJ; Scholten ET; Verschakelen J; Prokop M; Oudkerk M
    Eur J Radiol; 2009 Jun; 70(3):492-8. PubMed ID: 18417311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Malignancy risk estimation of pulmonary nodules in screening CTs: Comparison between a computer model and human observers.
    van Riel SJ; Ciompi F; Winkler Wille MM; Dirksen A; Lam S; Scholten ET; Rossi SE; Sverzellati N; Naqibullah M; Wittenberg R; Hovinga-de Boer MC; Snoeren M; Peters-Bax L; Mets O; Brink M; Prokop M; Schaefer-Prokop C; van Ginneken B
    PLoS One; 2017; 12(11):e0185032. PubMed ID: 29121063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.